Results 221 to 230 of about 258,109 (297)

An Exploratory Study to Identify Factors Associated with Recurrence of Generalized Pustular Psoriasis Flares in Adult Patients in Japan. [PDF]

Acta Derm Venereol
Morita A, Okubo Y, Okuyama R, Mizutani Y, Kanazawa N, Otsuka A, Miyagi T, Shionoya M, Mizuno R, Saitoh M, Imafuku S.   +10 more
europepmc   +1 more source

Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US

The Journal of Dermatology, EarlyView.
ABSTRACT Vitiligo is a chronic autoimmune depigmenting disease characterized by loss of pigment in the skin, hair, or both. As treatment options evolve, particularly with the emergence of oral Janus kinase inhibitors and dual Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor, it is essential to assess ...
Kennedy Cook, Nada M. Elbuluk, Roni Adiri, Alexandre Lejeune, Thomas Edwards, Milena A. Gianfrancesco, Scott P. Kelly, Tatjana Lukic, Edward Nagy, Samantha K. Kurosky, Lynne Napatalung, Iltefat Hamzavi   +11 more
wiley   +1 more source

Machine learning meets psoriasis: identifying key lactylation biomarkers as potential targets for diagnosis and therapies. [PDF]

Front Immunol
Li S, Qi Y, Qiao D, Hu X, Yao L, Cui X.
europepmc   +1 more source

Theorizing causality: A qualitative study of xylazine‐related wound diversity and perceived etiology among people who inject drugs

Addiction, EarlyView.
Abstract Background and aims Incidence and severity of opioid‐associated skin and soft‐tissue infections, often requiring intensive and costly medical care, have increased substantially since the emergence of xylazine in the US drug supply. Although progress has been made in clinical and harm reduction recommendations for treating xylazine‐related ...
Danielle German, Kelci Villarroel, Meredith Denney, Adrian Guta, Julie Evans, Jason Bienert, Alex Fidler, Kim Ashburn, Zach Kosinski, Becky L. Genberg   +9 more
wiley   +1 more source

Evaluation of +49 A>G (rs231775) Variant in CTLA4 Gene and SCTLA-4 Serum Levels in Plaque Psoriasis in a Mestizo Mexican Population. [PDF]

Int J Mol Sci
Cortés-Ruiz MG, Wheber-Hidalgo KA, Hernández-Nicols BF, Buenrostro-Camacho FG, Hernández-Bello J, Graciano-Machuca O, Alvarado-Navarro A.   +6 more
europepmc   +1 more source

Dermatoscopy of Immune‐Related Cutaneous Adverse Events: Current Insights and Clinical Implications

JEADV Clinical Practice, EarlyView.
Davide Fattore, Zoe Apalla
wiley   +1 more source

Role of dendritic cells and B cells in the skin of imiquimod (IMQ)-induced psoriasis-like mouse model. [PDF]

PeerJ
Mohd Noor AA, Lambuk L, Ahmad F, Azlan M, Mohd Redzwan N.   +4 more
europepmc   +1 more source

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim, Jacqueline Tu, Kelvin Truong, Gloria Fong, William Luu, Peter Barclay, Melanie Wong, Li‐Chuen Wong   +7 more
wiley   +1 more source

Evaluation of serum TWEAK levels and treatment response in psoriasis and psoriatic arthritis: a prospective comparative case-control study of adalimumab and methotrexate. [PDF]

Clin Rheumatol
Hegazy EM, Sadek EA, Ahmed SS.
europepmc   +1 more source

Causal Associations Between Chronic Inflammatory Skin Diseases and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study. [PDF]

Clin Cosmet Investig Dermatol
Cai Y, Dai W, Liu F, Li Z, Liu G.
europepmc   +1 more source